Understanding the multiple biological aspects leading to myeloma
about
Immunotherapy in Multiple Myeloma Using Cancer-Testis AntigensPrognostic indicators of lenalidomide for multiple myeloma: consensus and controversy.Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.Comparative Analysis of Quantitative Parameters of Expression of the Retinoic Acid Nuclear Receptor RARα Gene and APE1/YB-1/MDR1 Pattern Genes in Patients with Newly Detected Multiple Myeloma.Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death.Cellular immunotherapy on primary multiple myeloma expanded in a 3D bone marrow niche model.Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)
P2860
Q26774913-916874B8-2A1E-4108-B400-05F2D95C0B62Q38462720-23CCFBBC-E86E-4828-974C-E275C200F269Q39137683-29EC657C-0109-4C93-9544-2749AA485708Q50100772-1C901ADC-BF4D-4B0B-B1D6-509E461C1B73Q55086372-45808214-9314-4B5B-ADFA-4EB658834AADQ55261755-30E47295-0302-47A2-8C97-DD81F0D821C4Q59135626-96F7F97A-75F6-4265-9144-8186C2285C64
P2860
Understanding the multiple biological aspects leading to myeloma
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Understanding the multiple biological aspects leading to myeloma
@en
Understanding the multiple biological aspects leading to myeloma
@nl
type
label
Understanding the multiple biological aspects leading to myeloma
@en
Understanding the multiple biological aspects leading to myeloma
@nl
prefLabel
Understanding the multiple biological aspects leading to myeloma
@en
Understanding the multiple biological aspects leading to myeloma
@nl
P2860
P1433
P1476
Understanding the multiple biological aspects leading to myeloma
@en
P2093
Faith E Davies
Xavier Leleu
P2860
P304
P356
10.3324/HAEMATOL.2013.097907
P577
2014-04-01T00:00:00Z